vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and FTAI Infrastructure Inc. (FIP). Click either name above to swap in a different company.

Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $143.5M, roughly 1.2× FTAI Infrastructure Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 77.7%). Over the past eight quarters, FTAI Infrastructure Inc.'s revenue compounded faster (31.9% CAGR vs 10.6%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

FTAI Infrastructure Inc. owns, operates and invests in high-quality critical infrastructure assets across core sectors including transportation logistics, midstream energy, and power generation. It primarily serves North American markets, focusing on assets with stable long-term cash flows, contracted revenue streams, and strong market positions to deliver sustainable returns for stakeholders.

ESPR vs FIP — Head-to-Head

Bigger by revenue
ESPR
ESPR
1.2× larger
ESPR
$168.4M
$143.5M
FIP
Growing faster (revenue YoY)
ESPR
ESPR
+66.0% gap
ESPR
143.7%
77.7%
FIP
Faster 2-yr revenue CAGR
FIP
FIP
Annualised
FIP
31.9%
10.6%
ESPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
FIP
FIP
Revenue
$168.4M
$143.5M
Net Profit
$-97.7M
Gross Margin
Operating Margin
50.6%
-45.7%
Net Margin
-68.1%
Revenue YoY
143.7%
77.7%
Net Profit YoY
21.6%
EPS (diluted)
$0.32
$-1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
FIP
FIP
Q4 25
$168.4M
$143.5M
Q3 25
$87.3M
$140.6M
Q2 25
$82.4M
$122.3M
Q1 25
$65.0M
$96.2M
Q4 24
$69.1M
$80.8M
Q3 24
$51.6M
$83.3M
Q2 24
$73.8M
$84.9M
Q1 24
$137.7M
$82.5M
Net Profit
ESPR
ESPR
FIP
FIP
Q4 25
$-97.7M
Q3 25
$-31.3M
$-104.5M
Q2 25
$-12.7M
$-70.0M
Q1 25
$-40.5M
$120.2M
Q4 24
$-124.7M
Q3 24
$-29.5M
$-43.0M
Q2 24
$-61.9M
$-48.1M
Q1 24
$61.0M
$-50.3M
Operating Margin
ESPR
ESPR
FIP
FIP
Q4 25
50.6%
-45.7%
Q3 25
-11.4%
-70.8%
Q2 25
8.6%
-56.4%
Q1 25
-34.0%
81.8%
Q4 24
-6.4%
-152.7%
Q3 24
-31.0%
-51.7%
Q2 24
3.5%
-56.4%
Q1 24
52.5%
-58.8%
Net Margin
ESPR
ESPR
FIP
FIP
Q4 25
-68.1%
Q3 25
-35.9%
-74.4%
Q2 25
-15.4%
-57.2%
Q1 25
-62.2%
125.0%
Q4 24
-154.4%
Q3 24
-57.2%
-51.6%
Q2 24
-83.9%
-56.7%
Q1 24
44.3%
-60.9%
EPS (diluted)
ESPR
ESPR
FIP
FIP
Q4 25
$0.32
$-1.04
Q3 25
$-0.16
$-1.38
Q2 25
$-0.06
$-0.73
Q1 25
$-0.21
$0.89
Q4 24
$-0.14
$-1.21
Q3 24
$-0.15
$-0.45
Q2 24
$-0.33
$-0.52
Q1 24
$0.34
$-0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
FIP
FIP
Cash + ST InvestmentsLiquidity on hand
$167.9M
$57.4M
Total DebtLower is stronger
$3.8B
Stockholders' EquityBook value
$-302.0M
$21.3M
Total Assets
$465.9M
$5.7B
Debt / EquityLower = less leverage
176.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
FIP
FIP
Q4 25
$167.9M
$57.4M
Q3 25
$92.4M
$34.7M
Q2 25
$86.1M
$33.6M
Q1 25
$114.6M
$26.3M
Q4 24
$144.8M
$27.8M
Q3 24
$144.7M
$20.3M
Q2 24
$189.3M
$33.1M
Q1 24
$226.6M
$23.0M
Total Debt
ESPR
ESPR
FIP
FIP
Q4 25
$3.8B
Q3 25
$3.7B
Q2 25
$3.1B
Q1 25
$2.8B
Q4 24
$1.6B
Q3 24
$1.5B
Q2 24
$1.6B
Q1 24
$1.3B
Stockholders' Equity
ESPR
ESPR
FIP
FIP
Q4 25
$-302.0M
$21.3M
Q3 25
$-451.4M
$181.1M
Q2 25
$-433.5M
$375.5M
Q1 25
$-426.2M
$476.2M
Q4 24
$-388.7M
$202.7M
Q3 24
$-370.2M
$370.8M
Q2 24
$-344.2M
$394.8M
Q1 24
$-294.3M
$402.5M
Total Assets
ESPR
ESPR
FIP
FIP
Q4 25
$465.9M
$5.7B
Q3 25
$364.0M
$5.5B
Q2 25
$347.1M
$4.4B
Q1 25
$324.0M
$4.1B
Q4 24
$343.8M
$2.4B
Q3 24
$314.1M
$2.4B
Q2 24
$352.3M
$2.5B
Q1 24
$373.1M
$2.3B
Debt / Equity
ESPR
ESPR
FIP
FIP
Q4 25
176.99×
Q3 25
20.59×
Q2 25
8.21×
Q1 25
5.79×
Q4 24
7.84×
Q3 24
4.14×
Q2 24
3.94×
Q1 24
3.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
FIP
FIP
Operating Cash FlowLast quarter
$45.2M
$-2.8M
Free Cash FlowOCF − Capex
$-68.6M
FCF MarginFCF / Revenue
-47.8%
Capex IntensityCapex / Revenue
0.0%
45.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-398.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
FIP
FIP
Q4 25
$45.2M
$-2.8M
Q3 25
$-4.3M
$-24.4M
Q2 25
$-31.4M
$-5.2M
Q1 25
$-22.6M
$-85.7M
Q4 24
$-35.0M
$-8.1M
Q3 24
$-35.3M
$14.2M
Q2 24
$-7.2M
$-17.6M
Q1 24
$53.8M
$-3.9M
Free Cash Flow
ESPR
ESPR
FIP
FIP
Q4 25
$-68.6M
Q3 25
$-90.7M
Q2 25
$-87.5M
Q1 25
$-151.7M
Q4 24
$-34.3M
Q3 24
$-35.5M
$-11.7M
Q2 24
$-7.3M
$-32.1M
Q1 24
$53.8M
$-16.7M
FCF Margin
ESPR
ESPR
FIP
FIP
Q4 25
-47.8%
Q3 25
-64.5%
Q2 25
-71.6%
Q1 25
-157.7%
Q4 24
-42.4%
Q3 24
-68.7%
-14.0%
Q2 24
-9.9%
-37.9%
Q1 24
39.0%
-20.3%
Capex Intensity
ESPR
ESPR
FIP
FIP
Q4 25
0.0%
45.9%
Q3 25
0.0%
47.2%
Q2 25
0.0%
67.3%
Q1 25
0.0%
68.6%
Q4 24
0.0%
32.5%
Q3 24
0.3%
31.1%
Q2 24
0.1%
17.2%
Q1 24
0.1%
15.6%
Cash Conversion
ESPR
ESPR
FIP
FIP
Q4 25
Q3 25
Q2 25
Q1 25
-0.71×
Q4 24
Q3 24
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

FIP
FIP

Power Revenues$45.9M32%
Rail Revenue$44.6M31%
Service Other$22.8M16%
Gas Revenues$15.3M11%
Roadside Services Revenues$11.5M8%
Rapauno$1.2M1%

Related Comparisons